233 related articles for article (PubMed ID: 27043022)
1. Treating hepatitis B virus/hepatitis C virus coinfected patients with direct-acting hepatitis C virus antivirals only is not safe.
Ozaras R; Sunbul M; Parlak M; Bodur H; Leblebicioglu H
Hepatology; 2016 Nov; 64(5):1825-1827. PubMed ID: 27043022
[No Abstract] [Full Text] [Related]
2. Concomitant Treatment of Hepatitis C Virus and Diffuse Large B-Cell Lymphoma with Direct-Acting Antivirals in HIV Coinfection: A Case Report.
Gallipani A; Cha A; Berkowitz L; Bakshi A
J Int Assoc Provid AIDS Care; 2019; 18():2325958218822062. PubMed ID: 30798652
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on dual hepatitis B and C infection in Taiwan.
Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
[TBL] [Abstract][Full Text] [Related]
4. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
Zeremski M; Martinez AD; Talal AH
Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
[No Abstract] [Full Text] [Related]
5. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
Moorman AC; Xing J; Rupp LB; Gordon SC; Spradling PR; Boscarino JA; Schmidt MA; Daida YG; Teshale EH; Holmberg SD;
Gastroenterology; 2018 Feb; 154(3):754-758. PubMed ID: 29360428
[No Abstract] [Full Text] [Related]
7. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of HIV-/HCV-coinfected patients in the era of direct acting antivirals: is advanced liver disease still a limiting factor?
Gonzales Zamora JA
Infect Dis (Lond); 2018 Apr; 50(4):320-323. PubMed ID: 29129120
[No Abstract] [Full Text] [Related]
9. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
10. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
Bruno R; Fagiuoli S; Sacchi P
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
[No Abstract] [Full Text] [Related]
11. Hepatitis B and C Viruses and Biologics.
Grewal P; Sanghera R
Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
Belperio PS; Shahoumian TA; Mole LA; Backus LI
Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
14. 18th International Conference on Antiviral Research. Antivirals.
Kibble A
IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
[No Abstract] [Full Text] [Related]
15. [Interferon].
Tamori A; Kawada N
Nihon Rinsho; 2012 Apr; 70(4):620-4. PubMed ID: 22568143
[TBL] [Abstract][Full Text] [Related]
16. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
[TBL] [Abstract][Full Text] [Related]
19. [Predictive factors of response to Direct Acting Antivirals therapy Drug resistance hepatitis C virus].
Suda G; Yamasaki K; Sakamoto N
Nihon Rinsho; 2015 Dec; 73 Suppl 9():189-92. PubMed ID: 26845928
[No Abstract] [Full Text] [Related]
20. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis.
Arora U; Garg P; Agarwal S; Nischal N; Shalimar ; Wig N
Lancet Infect Dis; 2021 Dec; 21(12):e399-e406. PubMed ID: 34023004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
